查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1566929

急性缺血性腦中風診斷市場：按技術、最終用戶分類：2024-2033 年全球機會分析與產業預測

Acute Ischemic Stroke Diagnosis Market By Technology , By End User : Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 228 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

急性缺血性腦中風診斷市場

2023年，急性缺血性腦中風診斷市值為21億美元，預計2024年至2033年複合年成長率為5.7%，到2033年將達到36億美元。

急性缺血性腦中風（AIS）是一種致命的疾病，其中流向大腦的血液突然中斷，導致神經功能障礙。閉塞通常是由血栓或栓子引起，導致腦組織缺血或梗塞。突然虛弱、說話或理解困難、身體一側麻木、視力模糊、嚴重頭痛和頭暈是 AIS 最常見的症狀。 AIS 的即時診斷需要臨床評估和 CT 或 MRI 神經影像學檢查，這對於及時恢復血流和減少腦損傷至關重要。

AIS 盛行率的不斷上升，尤其是在老年人中，正在推動對急性缺血性腦中風診斷的需求。世界各地的老年人口正在迅速增加，生活方式的動態變化正在增加老年人中危及生命的疾病的發病率。此外，醫療保健和診斷技術支出的激增是市場的主要促進因素。動脈自旋標記等非侵入性成像技術是 AIS 診斷的最新趨勢。此類技術可以非侵入性地測量腦血流量，有助於透過快速、準確的診斷來評估組織活力。

然而，與這種尖端診斷技術相關的成本令人望而卻步，阻礙了低收入者利用其優勢並阻礙了市場開拓。此外，急性缺血性腦中風診斷的報銷情況高度不一致且具有挑戰性，限制了市場的成長。另一方面，政府為減少 AIS 盛行率所做的持續努力預計將為市場提供利潤豐厚的機會。例如，歐洲中風組織於2018年發起了舉措，旨在2030年改善中風預防行為。

分部審查

急性缺血性腦中風診斷市場分為技術、最終用戶和地區。依技術分為CT、MRI、頸動脈超音波、腦血管攝影、心電圖、超音波心臟檢查等。依最終使用者分類，可分為醫院/診所、門診手術中心、診斷實驗室/影像中心等。從區域來看，分析包括北美、歐洲、亞太地區和拉丁美洲地區。

主要發現

從技術角度來看，CT（電腦斷層掃描）領域將在2023年佔據較高的市場佔有率。

按最終用戶分類，醫院和診所部門將在 2023 年成為最大股東。

按地區分類，預計到 2023 年，北美地區的收益最高。

可以自訂此報告（需要額外的成本和時間表）。

  • 監管指引
  • 根據客戶興趣加入公司簡介
  • 按國家或地區進行的附加分析 – 市場規模和預測
  • 公司簡介的擴充列表
  • 歷史市場資料

目錄

第1章簡介

第 2 章執行摘要

第3章 市場狀況

  • 市場定義和範圍
  • 主要發現
    • 主要投資機會
    • 關鍵成功策略
  • 波特五力分析
  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會

第4章急性缺血性腦中風診斷市場：依技術分類

  • 市場概況
  • 電腦斷層掃描
  • 磁振造影
  • 頸動脈超音波
  • 腦血管攝影
  • 心電圖
  • 心臟超音波圖
  • 其他

第5章急性缺血性腦中風診斷市場：依最終用戶分類

  • 市場概況
  • 醫院和診所
  • 門診手術中心
  • 診斷實驗室和診斷影像中心
  • 其他

第6章急性缺血性腦中風診斷市場：按地區

  • 市場概況
  • 北美洲
    • 主要市場趨勢和機遇
    • 美國急性缺血性腦中風診斷市場
    • 加拿大急性缺血性腦中風診斷市場
    • 墨西哥急性缺血性腦中風診斷市場
  • 歐洲
    • 主要市場趨勢和機遇
    • 德國急性缺血性腦中風診斷市場
    • 法國急性缺血性腦中風診斷市場
    • 英國急性缺血性腦中風診斷市場
    • 義大利急性缺血性腦中風診斷市場
    • 西班牙急性缺血性腦中風診斷市場
    • 其他歐洲國家缺血性中風診斷市場
  • 亞太地區
    • 主要市場趨勢和機遇
    • 日本急性缺血性腦中風診斷市場
    • 中國急性缺血性腦中風腦中風診斷市場
    • 印度缺血性中風診斷市場
    • 澳洲缺血性中風診斷市場
    • 韓國急性缺血性腦中風診斷市場
    • 其他亞太地區缺血性中風診斷市場
  • 拉丁美洲/中東/非洲
    • 主要市場趨勢和機遇
    • 巴西缺血性中風診斷市場
    • 沙烏地阿拉伯缺血性中風診斷市場
    • 南非缺血性中風診斷市場
    • 其他拉丁美洲/中東/非洲急性缺血性腦中風診斷市場

第7章 競爭格局

  • 介紹
  • 關鍵成功策略
  • 10家主要企業產品圖譜
  • 競爭對手儀表板
  • 競爭熱圖
  • 主要企業定位（2023年）

第8章 公司簡介

  • Koninklijke Philips NV
  • GE Healthcare
  • Canon Inc.
  • Simens
  • Terumo Corporation
  • Stryker
  • Fujifilm Holdings Corporation
  • Samsung Electronics Co. Ltd
  • F. Hoffmann-La Roche Ltd
  • Boehringer Ingelheim International GmbH
簡介目錄
Product Code: A323961

Acute Ischemic Stroke Diagnosis Market

The acute ischemic stroke diagnosis market was valued at $2.1 billion in 2023 and is projected to reach $3.6 billion by 2033, growing at a CAGR of 5.7% from 2024 to 2033.

Acute ischemic stroke (AIS) is a fatal condition that includes abrupt obstruction of blood flow to the brain, leading to neurological dysfunction. The blockage is typically caused due to a thrombus or embolus, resulting in brain tissue ischemia and infarction. Sudden weakness, difficulty speaking or understanding speech, numbness on one side of the body, vision problems, severe headaches, and dizziness are the most common symptoms of AIS. Immediate diagnosis for the condition involves clinical assessment and neuroimaging via CT or MRI, which is pivotal to timely restore the blood flow and reduce brain damage.

Increase in the prevalence of AIS, particularly in the elderly population, is boosting the demand for acute ischemic stroke diagnosis. The elderly population is growing exponentially across the globe and dynamic changes in lifestyle are leading to rise in the occurrence of life-threatening conditions among them. Moreover, surge in expenditure on healthcare and diagnostic technologies is a key driver of the market. Non-invasive imaging techniques such as arterial spin labeling are trending for the diagnosis of AIS in recent times. Such techniques enable measurement of cerebral blood flow non-invasively, hence helping to assess the tissue viability with quick & precise diagnosis.

However, the expense associated with such cutting-edge diagnosis techniques is significantly high which prevents the low-income population from leveraging its benefits, hence hampering the market development. Moreover, the reimbursement landscape for acute ischemic stroke diagnosis is highly inconsistent and challenging, thereby restricting the growth of the market. On the contrary, the consistent efforts by government to reduce the prevalence of AIS is anticipated to present lucrative opportunities for the market. For instance, the European Stroke Organization began an initiative called Stroke Action Plan for Europe in 2018 which aims to improve the preventive action for stroke until 2030.

Segment Review

The acute ischemic stroke diagnosis market is segmented into technology, end user, and region. On the basis of technology, the market is divided into computed tomography, magnetic resonance imaging, carotid ultrasound, cerebral angiography, electrocardiography, echocardiography, and others. Depending on end user, it is classified into hospitals & clinics, ambulatory surgery centers, diagnostic laboratories and imaging centers, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of technology, the computed tomography segment acquired high stakes at the market in 2023.

Depending on end user, the hospitals & clinics segment was the highest shareholder in 2023.

Region wise, North America is poised to be the highest revenue generator by 2023.

Competition Analysis

The major players operating in the global acute ischemic stroke diagnosis market include Koninklijke Philips N.V., GE Healthcare, Canon Inc., Simens, Terumo Corporation, Stryker, Fujifilm Holdings Corporation, Samsung Electronics Co. Ltd, F. Hoffmann-La Roche Ltd, and Boehringer Ingelheim International GmbH. These players have adopted various key developmental strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data

Key Market Segments

By Technology

  • Computed Tomography
  • Magnetic Resonance Imaging
  • Carotid Ultrasound
  • Cerebral Angiography
  • Electrocardiography
  • Echocardiography
  • Others

By End User

  • Hospitals and Clinics
  • Ambulatory Surgery Centers
  • Diagnostic Laboratories and Imaging Centers
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Koninklijke Philips N.V.
    • GE Healthcare
    • Canon Inc.
    • Simens
    • Terumo Corporation
    • Stryker
    • Fujifilm Holdings Corporation
    • Samsung Electronics Co. Ltd
    • F. Hoffmann-La Roche Ltd
    • Boehringer Ingelheim International GmbH

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY TECHNOLOGY

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Technology
  • 4.2. Computed Tomography
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Magnetic Resonance Imaging
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country
  • 4.4. Carotid Ultrasound
    • 4.4.1. Key Market Trends, Growth Factors and Opportunities
    • 4.4.2. Market Size and Forecast, By Region
    • 4.4.3. Market Share Analysis, By Country
  • 4.5. Cerebral Angiography
    • 4.5.1. Key Market Trends, Growth Factors and Opportunities
    • 4.5.2. Market Size and Forecast, By Region
    • 4.5.3. Market Share Analysis, By Country
  • 4.6. Electrocardiography
    • 4.6.1. Key Market Trends, Growth Factors and Opportunities
    • 4.6.2. Market Size and Forecast, By Region
    • 4.6.3. Market Share Analysis, By Country
  • 4.7. Echocardiography
    • 4.7.1. Key Market Trends, Growth Factors and Opportunities
    • 4.7.2. Market Size and Forecast, By Region
    • 4.7.3. Market Share Analysis, By Country
  • 4.8. Others
    • 4.8.1. Key Market Trends, Growth Factors and Opportunities
    • 4.8.2. Market Size and Forecast, By Region
    • 4.8.3. Market Share Analysis, By Country

CHAPTER 5: ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY END USER

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By End User
  • 5.2. Hospitals And Clinics
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Ambulatory Surgery Centers
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Diagnostic Laboratories And Imaging Centers
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country
  • 5.5. Others
    • 5.5.1. Key Market Trends, Growth Factors and Opportunities
    • 5.5.2. Market Size and Forecast, By Region
    • 5.5.3. Market Share Analysis, By Country

CHAPTER 6: ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY REGION

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By Region
  • 6.2. North America
    • 6.2.1. Key Market Trends and Opportunities
    • 6.2.2. Market Size and Forecast, By Technology
    • 6.2.3. Market Size and Forecast, By End User
    • 6.2.4. Market Size and Forecast, By Country
    • 6.2.5. U.S. Acute Ischemic Stroke Diagnosis Market
      • 6.2.5.1. Market Size and Forecast, By Technology
      • 6.2.5.2. Market Size and Forecast, By End User
    • 6.2.6. Canada Acute Ischemic Stroke Diagnosis Market
      • 6.2.6.1. Market Size and Forecast, By Technology
      • 6.2.6.2. Market Size and Forecast, By End User
    • 6.2.7. Mexico Acute Ischemic Stroke Diagnosis Market
      • 6.2.7.1. Market Size and Forecast, By Technology
      • 6.2.7.2. Market Size and Forecast, By End User
  • 6.3. Europe
    • 6.3.1. Key Market Trends and Opportunities
    • 6.3.2. Market Size and Forecast, By Technology
    • 6.3.3. Market Size and Forecast, By End User
    • 6.3.4. Market Size and Forecast, By Country
    • 6.3.5. Germany Acute Ischemic Stroke Diagnosis Market
      • 6.3.5.1. Market Size and Forecast, By Technology
      • 6.3.5.2. Market Size and Forecast, By End User
    • 6.3.6. France Acute Ischemic Stroke Diagnosis Market
      • 6.3.6.1. Market Size and Forecast, By Technology
      • 6.3.6.2. Market Size and Forecast, By End User
    • 6.3.7. UK Acute Ischemic Stroke Diagnosis Market
      • 6.3.7.1. Market Size and Forecast, By Technology
      • 6.3.7.2. Market Size and Forecast, By End User
    • 6.3.8. Italy Acute Ischemic Stroke Diagnosis Market
      • 6.3.8.1. Market Size and Forecast, By Technology
      • 6.3.8.2. Market Size and Forecast, By End User
    • 6.3.9. Spain Acute Ischemic Stroke Diagnosis Market
      • 6.3.9.1. Market Size and Forecast, By Technology
      • 6.3.9.2. Market Size and Forecast, By End User
    • 6.3.10. Rest of Europe Acute Ischemic Stroke Diagnosis Market
      • 6.3.10.1. Market Size and Forecast, By Technology
      • 6.3.10.2. Market Size and Forecast, By End User
  • 6.4. Asia-Pacific
    • 6.4.1. Key Market Trends and Opportunities
    • 6.4.2. Market Size and Forecast, By Technology
    • 6.4.3. Market Size and Forecast, By End User
    • 6.4.4. Market Size and Forecast, By Country
    • 6.4.5. Japan Acute Ischemic Stroke Diagnosis Market
      • 6.4.5.1. Market Size and Forecast, By Technology
      • 6.4.5.2. Market Size and Forecast, By End User
    • 6.4.6. China Acute Ischemic Stroke Diagnosis Market
      • 6.4.6.1. Market Size and Forecast, By Technology
      • 6.4.6.2. Market Size and Forecast, By End User
    • 6.4.7. India Acute Ischemic Stroke Diagnosis Market
      • 6.4.7.1. Market Size and Forecast, By Technology
      • 6.4.7.2. Market Size and Forecast, By End User
    • 6.4.8. Australia Acute Ischemic Stroke Diagnosis Market
      • 6.4.8.1. Market Size and Forecast, By Technology
      • 6.4.8.2. Market Size and Forecast, By End User
    • 6.4.9. South Korea Acute Ischemic Stroke Diagnosis Market
      • 6.4.9.1. Market Size and Forecast, By Technology
      • 6.4.9.2. Market Size and Forecast, By End User
    • 6.4.10. Rest of Asia-Pacific Acute Ischemic Stroke Diagnosis Market
      • 6.4.10.1. Market Size and Forecast, By Technology
      • 6.4.10.2. Market Size and Forecast, By End User
  • 6.5. LAMEA
    • 6.5.1. Key Market Trends and Opportunities
    • 6.5.2. Market Size and Forecast, By Technology
    • 6.5.3. Market Size and Forecast, By End User
    • 6.5.4. Market Size and Forecast, By Country
    • 6.5.5. Brazil Acute Ischemic Stroke Diagnosis Market
      • 6.5.5.1. Market Size and Forecast, By Technology
      • 6.5.5.2. Market Size and Forecast, By End User
    • 6.5.6. Saudi Arabia Acute Ischemic Stroke Diagnosis Market
      • 6.5.6.1. Market Size and Forecast, By Technology
      • 6.5.6.2. Market Size and Forecast, By End User
    • 6.5.7. South Africa Acute Ischemic Stroke Diagnosis Market
      • 6.5.7.1. Market Size and Forecast, By Technology
      • 6.5.7.2. Market Size and Forecast, By End User
    • 6.5.8. Rest of LAMEA Acute Ischemic Stroke Diagnosis Market
      • 6.5.8.1. Market Size and Forecast, By Technology
      • 6.5.8.2. Market Size and Forecast, By End User

CHAPTER 7: COMPETITIVE LANDSCAPE

  • 7.1. Introduction
  • 7.2. Top Winning Strategies
  • 7.3. Product Mapping of Top 10 Player
  • 7.4. Competitive Dashboard
  • 7.5. Competitive Heatmap
  • 7.6. Top Player Positioning, 2023

CHAPTER 8: COMPANY PROFILES

  • 8.1. Koninklijke Philips N.V.
    • 8.1.1. Company Overview
    • 8.1.2. Key Executives
    • 8.1.3. Company Snapshot
    • 8.1.4. Operating Business Segments
    • 8.1.5. Product Portfolio
    • 8.1.6. Business Performance
    • 8.1.7. Key Strategic Moves and Developments
  • 8.2. GE Healthcare
    • 8.2.1. Company Overview
    • 8.2.2. Key Executives
    • 8.2.3. Company Snapshot
    • 8.2.4. Operating Business Segments
    • 8.2.5. Product Portfolio
    • 8.2.6. Business Performance
    • 8.2.7. Key Strategic Moves and Developments
  • 8.3. Canon Inc.
    • 8.3.1. Company Overview
    • 8.3.2. Key Executives
    • 8.3.3. Company Snapshot
    • 8.3.4. Operating Business Segments
    • 8.3.5. Product Portfolio
    • 8.3.6. Business Performance
    • 8.3.7. Key Strategic Moves and Developments
  • 8.4. Simens
    • 8.4.1. Company Overview
    • 8.4.2. Key Executives
    • 8.4.3. Company Snapshot
    • 8.4.4. Operating Business Segments
    • 8.4.5. Product Portfolio
    • 8.4.6. Business Performance
    • 8.4.7. Key Strategic Moves and Developments
  • 8.5. Terumo Corporation
    • 8.5.1. Company Overview
    • 8.5.2. Key Executives
    • 8.5.3. Company Snapshot
    • 8.5.4. Operating Business Segments
    • 8.5.5. Product Portfolio
    • 8.5.6. Business Performance
    • 8.5.7. Key Strategic Moves and Developments
  • 8.6. Stryker
    • 8.6.1. Company Overview
    • 8.6.2. Key Executives
    • 8.6.3. Company Snapshot
    • 8.6.4. Operating Business Segments
    • 8.6.5. Product Portfolio
    • 8.6.6. Business Performance
    • 8.6.7. Key Strategic Moves and Developments
  • 8.7. Fujifilm Holdings Corporation
    • 8.7.1. Company Overview
    • 8.7.2. Key Executives
    • 8.7.3. Company Snapshot
    • 8.7.4. Operating Business Segments
    • 8.7.5. Product Portfolio
    • 8.7.6. Business Performance
    • 8.7.7. Key Strategic Moves and Developments
  • 8.8. Samsung Electronics Co. Ltd
    • 8.8.1. Company Overview
    • 8.8.2. Key Executives
    • 8.8.3. Company Snapshot
    • 8.8.4. Operating Business Segments
    • 8.8.5. Product Portfolio
    • 8.8.6. Business Performance
    • 8.8.7. Key Strategic Moves and Developments
  • 8.9. F. Hoffmann-La Roche Ltd
    • 8.9.1. Company Overview
    • 8.9.2. Key Executives
    • 8.9.3. Company Snapshot
    • 8.9.4. Operating Business Segments
    • 8.9.5. Product Portfolio
    • 8.9.6. Business Performance
    • 8.9.7. Key Strategic Moves and Developments
  • 8.10. Boehringer Ingelheim International GmbH
    • 8.10.1. Company Overview
    • 8.10.2. Key Executives
    • 8.10.3. Company Snapshot
    • 8.10.4. Operating Business Segments
    • 8.10.5. Product Portfolio
    • 8.10.6. Business Performance
    • 8.10.7. Key Strategic Moves and Developments